These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 7937354)

  • 41. CCK-A- and CCK-B-like receptors in the gallbladder and stomach of the alligator (Alligator mississippiensis).
    Oliver AS; Vigna SR
    Gen Comp Endocrinol; 1997 Jan; 105(1):91-101. PubMed ID: 9000471
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Localization of cholecystokinin A and cholecystokinin B/gastrin receptors in the canine upper gastrointestinal tract.
    Mantyh CR; Pappas TN; Vigna SR
    Gastroenterology; 1994 Oct; 107(4):1019-30. PubMed ID: 7926455
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Examining the role of cholecystokinin in appetitive learning in the infant rat.
    Weller A; Tsitolovskya L; Gispan IH; Rabinovitz S
    Peptides; 2001 Aug; 22(8):1317-23. PubMed ID: 11457527
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Conformational analysis of possible biologically active (receptor-bound) conformations of peptides derived from cholecystokinin, cerulein and little gastrin and the opiate peptide, Met-enkephalin.
    Pincus MR; Murphy RB; Carty RP; Chen J; Shah D; Scheraga HA
    Peptides; 1988; 9 Suppl 1():145-52. PubMed ID: 2856638
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cholecystokinin in the central nervous system: a minireview.
    Beinfeld MC
    Neuropeptides; 1983 Oct; 3(6):411-27. PubMed ID: 6141537
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Postponement of satiety by blockade of brain cholecystokinin (CCK-B) receptors.
    Dourish CT; Rycroft W; Iversen SD
    Science; 1989 Sep; 245(4925):1509-11. PubMed ID: 2781294
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Decrease in exploratory behavior in naturally occurring cholecystokinin (CCK)-A receptor gene knockout rats.
    Kobayashi S; Ohta M; Miyasaka K; Funakoshi A
    Neurosci Lett; 1996 Aug; 214(1):61-4. PubMed ID: 8873132
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Central nervous system cholecystokinin and the control of feeding behavior in sheep.
    Della-Fera MA; Baile CA
    Prog Clin Biol Res; 1985; 192():115-22. PubMed ID: 3001747
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of cholecystokinin and opioid peptides in control of food intake.
    Baile CA; McLaughlin CL; Della-Fera MA
    Physiol Rev; 1986 Jan; 66(1):172-234. PubMed ID: 2868468
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Natural and synthetic CCK-58. Novel reagents for studying cholecystokinin physiology.
    Reeve JR; Eysselein VE; Ho FJ; Chew P; Vigna SR; Liddle RA; Evans C
    Ann N Y Acad Sci; 1994 Mar; 713():11-21. PubMed ID: 7514372
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of CCK-tetrapeptide analogues as potent and selective CCK-A receptor agonists.
    Shiosaki K; Lin CW; Kopecka H; Craig R; Wagenaar FL; Bianchi B; Miller T; Witte D; Nadzan AM
    J Med Chem; 1990 Nov; 33(11):2950-2. PubMed ID: 1700123
    [No Abstract]   [Full Text] [Related]  

  • 52. Cholecystokinin and adrenal-cortex secretion.
    Nussdorfer GG; Spinazzi R; Mazzocchi G
    Vitam Horm; 2005; 71():433-53. PubMed ID: 16112277
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Progress in developing cholecystokinin (CCK)/gastrin receptor ligands that have therapeutic potential.
    Berna MJ; Tapia JA; Sancho V; Jensen RT
    Curr Opin Pharmacol; 2007 Dec; 7(6):583-92. PubMed ID: 17997137
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Distinct receptors for cholecystokinin and gastrin on canine fundic D-cells.
    DelValle J; Chiba T; Park J; Yamada T
    Am J Physiol; 1993 May; 264(5 Pt 1):G811-5. PubMed ID: 8098910
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Different actions of CCK on pancreatic and gastric growth in the rat: effect of CCK(A) receptor blockade.
    Varga G; Kisfalvi K; Pelosini I; D'Amato M; Scarpignato C
    Br J Pharmacol; 1998 Jun; 124(3):435-40. PubMed ID: 9647465
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of tyrosine 189 and asparagine 358 of the cholecystokinin 2 receptor in direct interaction with the crucial C-terminal amide of cholecystokinin by molecular modeling, site-directed mutagenesis, and structure/affinity studies.
    Galés C; Poirot M; Taillefer J; Maigret B; Martinez J; Moroder L; Escrieut C; Pradayrol L; Fourmy D; Silvente-Poirot S
    Mol Pharmacol; 2003 May; 63(5):973-82. PubMed ID: 12695525
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Peptide/benzodiazepine hybrids as ligands of CCK(A) and CCK(B) receptors.
    Escherich A; Lutz J; Escrieut C; Fourmy D; van Neuren AS; Müller G; Schafferhans A; Klebe G; Moroder L
    Biopolymers; 2000-2001; 56(2):55-76. PubMed ID: 11592053
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Conserved cholecystokinin receptor transmembrane domain IV amino acids confer peptide affinity.
    Ren Y; Bläker M; Seshadri L; McBride EW; Beinborn M; Kopin AS
    J Mol Neurosci; 2003 Apr; 20(2):115-24. PubMed ID: 12794305
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantitative structure-activity relationship studies on cholecystokinin antagonists.
    Gupta SP
    Curr Pharm Des; 2002; 8(2):111-24. PubMed ID: 11812253
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cholecystokinin analogs with suppressed central activities.
    Maletínská L; Pírková J; Hlavácek J; Slaninová J
    Peptides; 1998; 19(2):301-8. PubMed ID: 9493862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.